128 related articles for article (PubMed ID: 15610453)
1. Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: long-term follow up of a pilot study.
Ikeda K; Kobayashi M; Saitoh S; Someya T; Hosaka T; Akuta N; Suzuki Y; Suzuki F; Tsubota A; Arase Y; Kumada H
J Gastroenterol Hepatol; 2005 Jan; 20(1):95-102. PubMed ID: 15610453
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
3. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
4. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
[TBL] [Abstract][Full Text] [Related]
5. [The clinical significance of quantitation of HBV DNA in serum-comparison of the branched-DNA assay with the second-generation digene hybrid capture assay and long-term observation].
Jun EJ; Han JY; Choi H; Chang UI; Lee TK; Kim YH; Kim JI; Park SH; Kim JK; Chung KW; Sun HS
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):157-66. PubMed ID: 12499801
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus DNA in patients with hepatitis B-related liver cirrhosis with or without hepatocellular carcinomas: a matched case-control study.
Xu J; Lin Y; Wang YP; Chen YX; Shi B; Lu J; Xie WF
J Dig Dis; 2009 May; 10(2):138-44. PubMed ID: 19426397
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus-related hepatocellular carcinogenesis and its prevention.
Ikeda K; Arase Y; Kobayashi M; Someya T; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Kumada H
Intervirology; 2005; 48(1):29-38. PubMed ID: 15785087
[TBL] [Abstract][Full Text] [Related]
8. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
Yuen MF; Tanaka Y; Shinkai N; Poon RT; But DY; Fong DY; Fung J; Wong DK; Yuen JC; Mizokami M; Lai CL
Gut; 2008 Jan; 57(1):98-102. PubMed ID: 17483190
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
10. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection.
Sezaki H; Kobayashi M; Hosaka T; Someya T; Akuta N; Suzuki F; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Sato J; Kumada H
J Gastroenterol; 2004 Jun; 39(6):550-6. PubMed ID: 15235872
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of interferon therapy on incidence of cirrhosis and hepatocellular carcinoma in Thai patients with chronic hepatitis B.
Tangkijvanich P; Thong-ngam D; Mahachai V; Kladchareon N; Suwangool P; Kullavanijaya P
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):452-8. PubMed ID: 11944697
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
16. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
[TBL] [Abstract][Full Text] [Related]
17. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.
Lin SM; Sheen IS; Chien RN; Chu CM; Liaw YF
Hepatology; 1999 Mar; 29(3):971-5. PubMed ID: 10051505
[TBL] [Abstract][Full Text] [Related]
18. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
[TBL] [Abstract][Full Text] [Related]
19. Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma?
Tanaka K; Sata M; Uchimura Y; Suzuki H; Tanikawa K
Oncol Rep; 1998; 5(1):205-8. PubMed ID: 9458323
[TBL] [Abstract][Full Text] [Related]
20. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]